Provention Bio, Inc. (PRVB) [Rocket]

In millions, except per share items	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21	Jun-30-21	Mar-31-21	Dec-31-20	Sep-30-20
	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q
Net income	-104.5	-104.0	-114.4	-121.2	-125.5	-118.4	-98.6	-76.5
Depreciation and amortization [+]	0.5	0.5	0.4	0.3	0.2	0.1	0.0
Depreciation	0.5	0.5	0.4	0.3	0.2	0.1	0.0
Stock-based compensation	12.2	12.3	11.8	17.2	16.8	14.8	13.2	6.4
Change in working capital [+]	-1.2	-4.2	-0.8	-1.3	5.0	12.5	8.8	8.7
Other current assets	-1.6	-1.7	-1.3	-0.3	-0.6	-3.0	-4.1	-2.9
Accounts payable	1.8	-1.0	-4.0	-3.5	-4.0	4.7	5.8	4.8
Accrued expenses	-1.6	-1.5	4.4	2.3	9.5	10.5	7.0	6.6
Other	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.1
Other operating activities	0.7	1.5	7.6	8.4	7.4	7.3	0.2	0.0
Cash from operations	-92.3	-93.9	-95.4	-96.6	-96.0	-83.7	-76.3	-61.4

Capital expenditures	-0.3	-0.7	-1.0	-1.7	-2.0	-1.4	-1.1	-0.4
Purchases of property and equipment	-0.3		-1.0	-1.7	-2.0	-1.4	-1.1	-0.4
Sales of short-term investments, net [+]		-13.0	-30.1	16.5	0.9	11.8	26.3	-28.9
Purchases of short-term investments			-55.3		-36.0	-32.1	-28.7	-70.9
Sales of short-term investments		29.9	25.2	36.8	36.9	43.8	55.0	42.0
Cash from investing	-15.4	-13.7	-31.1	14.8	-1.1	10.4	25.2	-29.3

Option exercises		0.0				1.0	1.2	0.9
Other cash from financing	13.8	2.2				217.5	115.4	137.7
Cash from financing	13.8	2.2	102.4	102.7	103.0	216.5	114.3	114.1

Free cash flow	-92.5	-94.6	-96.3	-98.2	-98.0	-85.0	-77.4	-61.8
Per share (diluted)	($1.45)	($1.49)	($1.53)	($1.63)	($1.67)	($1.54)	($1.51)	($1.27)